Gene Therapy and Regulation welcomes submissions of papers which report original research data on gene therapy, stem/progenitor cell therapy and tissue engineering, gene regulation, stem cell characterization/manipulation, epigenetic reprogramming, RNA/DNA transfer into mammalian cells and subsequent long term/transient gene expression, alteration or inactivation. Papers from both basic research (molecular cloning/sequencing, gene regulation/networks, design and development of vectors, delivery systems, biological and therapeutic effects, stem cell biology/engineering, cellular and animal models) and from gene/cell therapy clinical trials or investigations will be considered.